Previous Article | Next Article 
J Virol. 1988 January; 62(1): 196-205
Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.
D J Goldstein and
S K Weller
Department of Microbiology, University of Connecticut Health Center, Farmington 06032.
ABSTRACT
Herpes simplex virus (HSV) encodes a ribonucleotide reductase consisting of two subunits (140 and 38 kilodaltons) whose genes map to coordinates 0.56 to 0.60 on the viral genome. Host cell lines containing the HpaI F fragment which includes the reductase subunit genes of HSV type 1 strain KOS (coordinates 0.535 to 0.620) were generated. Transfection of these cells with a plasmid containing the immediate-early ICP0 gene resulted in the expression of ICP6; interestingly, ICP4 plasmids failed to induce expression, indicating an unusual pattern of ICP6 regulation. One such cell line (D14) was used to isolate a mutant with the structural gene of lacZ inserted into the ICP6 gene such that the lacZ gene is read in frame with the N-terminal region of ICP6. This mutant generated a protein containing 434 amino acids (38%) of the N terminus of ICP6 fused to beta-galactosidase under control of the endogenous ICP6 promoter. Screening for virus recombinants was greatly facilitated by staining virus plaques with 5-bromo-4-chloro-3-indoyl-beta-D-galactoside (X-gal). Enzyme assays of infected BHK cells indicated that the mutant is incapable of inducing viral ribonucleotide reductase activity. Surprisingly, although plaque size was greatly reduced, mutant virus yield was reduced only four- to fivefold compared with that of the wild type grown in exponentially growing Vero cells. Mutant virus plaque size, yields, and ability to synthesize viral DNA were more severely compromised in serum-starved cells as compared with the wild type grown under the same condition. Although our evidence suggests that the HSV type 1 ribonucleotide reductase is not required for virus growth and DNA replication in dividing cells, it may be required for growth in nondividing cells.
J Virol. 1988 January; 62(1): 196-205
This article has been cited by other articles:
-
Pinna, D., Oreste, P., Coradin, T., Kajaste-Rudnitski, A., Ghezzi, S., Zoppetti, G., Rotola, A., Argnani, R., Poli, G., Manservigi, R., Vicenzi, E.
(2008). Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide. Antimicrob. Agents Chemother.
52: 3078-3084
[Abstract]
[Full Text]
-
Akkarawongsa, R., Potocky, T. B., English, E. P., Gellman, S. H., Brandt, C. R.
(2008). Inhibition of Herpes Simplex Virus Type 1 Infection by Cationic {beta}-Peptides. Antimicrob. Agents Chemother.
52: 2120-2129
[Abstract]
[Full Text]
-
Mahller, Y. Y., Vaikunth, S. S., Ripberger, M. C., Baird, W. H., Saeki, Y., Cancelas, J. A., Crombleholme, T. M., Cripe, T. P.
(2008). Tissue Inhibitor of Metalloproteinase-3 via Oncolytic Herpesvirus Inhibits Tumor Growth and Vascular Progenitors. Cancer Res.
68: 1170-1179
[Abstract]
[Full Text]
-
Kolodkin-Gal, D., Zamir, G., Edden, Y., Pikarsky, E., Pikarsky, A., Haim, H., Haviv, Y. S., Panet, A.
(2008). Herpes Simplex Virus Type 1 Preferentially Targets Human Colon Carcinoma: Role of Extracellular Matrix. J. Virol.
82: 999-1010
[Abstract]
[Full Text]
-
Kurozumi, K., Hardcastle, J., Thakur, R., Yang, M., Christoforidis, G., Fulci, G., Hochberg, F. H., Weissleder, R., Carson, W., Chiocca, E. A., Kaur, B.
(2007). Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy. JNCI J Natl Cancer Inst
99: 1768-1781
[Abstract]
[Full Text]
-
Mulvey, M., Arias, C., Mohr, I.
(2007). Maintenance of Endoplasmic Reticulum (ER) Homeostasis in Herpes Simplex Virus Type 1-Infected Cells through the Association of a Viral Glycoprotein with PERK, a Cellular ER Stress Sensor. J. Virol.
81: 3377-3390
[Abstract]
[Full Text]
-
Hargett, D., Rice, S., Bachenheimer, S. L.
(2006). Herpes Simplex Virus Type 1 ICP27-Dependent Activation of NF-{kappa}B. J. Virol.
80: 10565-10578
[Abstract]
[Full Text]
-
Kuroda, T., Rabkin, S. D., Martuza, R. L.
(2006). Effective Treatment of Tumors with Strong {beta}-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector.. Cancer Res.
66: 10127-10135
[Abstract]
[Full Text]
-
Shah, A. C., Price, K. H., Parker, J. N., Samuel, S. L., Meleth, S., Cassady, K. A., Yancey Gillespie, G., Whitley, R. J., Markert, J. M.
(2006). Serial Passage through Human Glioma Xenografts Selects for a {Delta}{gamma}134.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors.. J. Virol.
80: 7308-7315
[Abstract]
[Full Text]
-
Mulvey, M., Arias, C., Mohr, I.
(2006). Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions.. J. Virol.
80: 7354-7363
[Abstract]
[Full Text]
-
Walsh, D., Mohr, I.
(2006). Assembly of an active translation initiation factor complex by a viral protein.. Genes Dev.
20: 461-472
[Abstract]
[Full Text]
-
Aghi, M., Rabkin, S., Martuza, R. L.
(2006). Effect of Chemotherapy-Induced DNA Repair on Oncolytic Herpes Simplex Viral Replication. JNCI J Natl Cancer Inst
98: 38-50
[Abstract]
[Full Text]
-
Hargett, D., McLean, T., Bachenheimer, S. L.
(2005). Herpes Simplex Virus ICP27 Activation of Stress Kinases JNK and p38. J. Virol.
79: 8348-8360
[Abstract]
[Full Text]
-
Liu, R., Varghese, S., Rabkin, S. D.
(2005). Oncolytic Herpes Simplex Virus Vector Therapy of Breast Cancer in C3(1)/SV40 T-antigen Transgenic Mice. Cancer Res.
65: 1532-1540
[Abstract]
[Full Text]
-
Davido, D. J., von Zagorski, W. F., Lane, W. S., Schaffer, P. A.
(2005). Phosphorylation Site Mutations Affect Herpes Simplex Virus Type 1 ICP0 Function. J. Virol.
79: 1232-1243
[Abstract]
[Full Text]
-
Moorman, N. J., Lin, C. Y., Speck, S. H.
(2004). Identification of Candidate Gammaherpesvirus 68 Genes Required for Virus Replication by Signature-Tagged Transposon Mutagenesis. J. Virol.
78: 10282-10290
[Abstract]
[Full Text]
-
Lembo, D., Donalisio, M., Hofer, A., Cornaglia, M., Brune, W., Koszinowski, U., Thelander, L., Landolfo, S.
(2004). The Ribonucleotide Reductase R1 Homolog of Murine Cytomegalovirus Is Not a Functional Enzyme Subunit but Is Required for Pathogenesis. J. Virol.
78: 4278-4288
[Abstract]
[Full Text]
-
Davido, D. J., von Zagorski, W. F., Maul, G. G., Schaffer, P. A.
(2003). The Differential Requirement for Cyclin-Dependent Kinase Activities Distinguishes Two Functions of Herpes Simplex Virus Type 1 ICP0. J. Virol.
77: 12603-12616
[Abstract]
[Full Text]
-
Przech, A. J., Yu, D., Weller, S. K.
(2003). Point Mutations in Exon I of the Herpes Simplex Virus Putative Terminase Subunit, UL15, Indicate that the Most Conserved Residues Are Essential for Cleavage and Packaging. J. Virol.
77: 9613-9621
[Abstract]
[Full Text]
-
Mullen, J. T., Tanabe, K. K.
(2003). Viral Oncolysis for Malignant Liver Tumors. Ann. Surg. Oncol.
10: 596-605
[Abstract]
[Full Text]
-
Cinatl, J. Jr., Cinatl, J., Michaelis, M., Kabickova, H., Kotchetkov, R., Vogel, J.-U., Doerr, H. W., Klingebiel, T., Driever, P. H.
(2003). Potent Oncolytic Activity of Multimutated Herpes Simplex Virus G207 in Combination with Vincristine against Human Rhabdomyosarcoma. Cancer Res.
63: 1508-1514
[Abstract]
[Full Text]
-
Palmer, D. H, Chen, M.-J., Kerr, D. J
(2002). Gene therapy for colorectal cancer. Br Med Bull
64: 201-225
[Abstract]
[Full Text]
-
Langelier, Y., Bergeron, S., Chabaud, S., Lippens, J., Guilbault, C., Sasseville, A. M.-J., Denis, S., Mosser, D. D., Massie, B.
(2002). The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J. Gen. Virol.
83: 2779-2789
[Abstract]
[Full Text]
-
Connolly, S. A., Landsburg, D. J., Carfi, A., Wiley, D. C., Eisenberg, R. J., Cohen, G. H.
(2002). Structure-Based Analysis of the Herpes Simplex Virus Glycoprotein D Binding Site Present on Herpesvirus Entry Mediator HveA (HVEM). J. Virol.
76: 10894-10904
[Abstract]
[Full Text]
-
Davido, D. J., Leib, D. A., Schaffer, P. A.
(2002). The Cyclin-Dependent Kinase Inhibitor Roscovitine Inhibits the Transactivating Activity and Alters the Posttranslational Modification of Herpes Simplex Virus Type 1 ICP0. J. Virol.
76: 1077-1088
[Abstract]
[Full Text]
-
Perkins, D., Pereira, E. F. R., Gober, M., Yarowsky, P. J., Aurelian, L.
(2002). The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Blocks Apoptosis in Hippocampal Neurons, Involving Activation of the MEK/MAPK Survival Pathway. J. Virol.
76: 1435-1449
[Abstract]
[Full Text]
-
Petrowsky, H., Roberts, G. D., Kooby, D. A., Burt, B. M., Bennett, J. J., Delman, K. A., Stanziale, S. F., Delohery, T. M., Tong, W. P., Federoff, H. J., Fong, Y.
(2001). Functional Interaction between Fluorodeoxyuridine-Induced Cellular Alterations and Replication of a Ribonucleotide Reductase-Negative Herpes Simplex Virus. J. Virol.
75: 7050-7058
[Abstract]
[Full Text]
-
Nakamura, H., Mullen, J. T., Chandrasekhar, S., Pawlik, T. M., Yoon, S. S., Tanabe, K. K.
(2001). Multimodality Therapy with a Replication-conditional Herpes Simplex Virus 1 Mutant that Expresses Yeast Cytosine Deaminase for Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil. Cancer Res.
61: 5447-5452
[Abstract]
[Full Text]
-
Yamamura, H., Hashio, M., Noguchi, M., Sugenoya, Y., Osakada, M., Hirano, N., Sasaki, Y., Yoden, T., Awata, N., Araki, N., Tatsuta, M., Miyatake, S.-I., Takahashi, K.
(2001). Identification of the Transcriptional Regulatory Sequences of Human Calponin Promoter and Their Use in Targeting a Conditionally Replicating Herpes Vector to Malignant Human Soft Tissue and Bone Tumors. Cancer Res.
61: 3969-3977
[Abstract]
[Full Text]
-
Hobbs, W. E., Brough, D. E., Kovesdi, I., DeLuca, N. A.
(2001). Efficient Activation of Viral Genomes by Levels of Herpes Simplex Virus ICP0 Insufficient To Affect Cellular Gene Expression or Cell Survival. J. Virol.
75: 3391-3403
[Abstract]
[Full Text]
-
Jacobs, A., Tjuvajev, J. G., Dubrovin, M., Akhurst, T., Balatoni, J., Beattie, B., Joshi, R., Finn, R., Larson, S. M., Herrlinger, U., Pechan, P. A., Chiocca, E. A., Breakefield, X. O., Blasberg, R. G.
(2001). Positron Emission Tomography-based Imaging of Transgene Expression Mediated by Replication-conditional, Oncolytic Herpes Simplex Virus Type 1 Mutant Vectors in Vivo. Cancer Res.
61: 2983-2995
[Abstract]
[Full Text]
-
Wu, A., Mazumder, A., Martuza, R. L., Liu, X., Thein, M., Meehan, K. R., Rabkin, S. D.
(2001). Biological Purging of Breast Cancer Cells Using an Attenuated Replication-competent Herpes Simplex Virus in Human Hematopoietic Stem Cell Transplantation. Cancer Res.
61: 3009-3015
[Abstract]
[Full Text]
-
Lembo, D., Gribaudo, G., Hofer, A., Riera, L., Cornaglia, M., Mondo, A., Angeretti, A., Gariglio, M., Thelander, L., Landolfo, S.
(2000). Expression of an Altered Ribonucleotide Reductase Activity Associated with the Replication of Murine Cytomegalovirus in Quiescent Fibroblasts. J. Virol.
74: 11557-11565
[Abstract]
[Full Text]
-
Smith, C. C., Nelson, J., Aurelian, L., Gober, M., Goswami, B. B.
(2000). Ras-GAP Binding and Phosphorylation by Herpes Simplex Virus Type 2 RR1 PK (ICP10) and Activation of the Ras/MEK/MAPK Mitogenic Pathway Are Required for Timely Onset of Virus Growth. J. Virol.
74: 10417-10429
[Abstract]
[Full Text]
-
Bearer, E. L., Breakefield, X. O., Schuback, D., Reese, T. S., LaVail, J. H.
(2000). Retrograde axonal transport of herpes simplex virus: Evidence for a single mechanism and a role for tegument. Proc. Natl. Acad. Sci. USA
97: 8146-8150
[Abstract]
[Full Text]
-
Palmer, J. A., Branston, R. H., Lilley, C. E., Robinson, M. J., Groutsi, F., Smith, J., Latchman, D. S., Coffin, R. S.
(2000). Development and Optimization of Herpes Simplex Virus Vectors for Multiple Long-Term Gene Delivery to the Peripheral Nervous System. J. Virol.
74: 5604-5618
[Abstract]
[Full Text]
-
Spencer, B., Agarwala, S., Miskulin, M., Smith, M., Brandt, C. R.
(2000). Herpes Simplex Virus-Mediated Gene Delivery to the Rodent Visual System. IOVS
41: 1392-1401
[Abstract]
[Full Text]
-
YOON, S. S., NAKAMURA, H., CARROLL, N. M., BODE, B. P., CHIOCCA, E. A., TANABE, K. K.
(2000). An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J.
14: 301-311
[Abstract]
[Full Text]
-
Whitbeck, J. C., Muggeridge, M. I., Rux, A. H., Hou, W., Krummenacher, C., Lou, H., van Geelen, A., Eisenberg, R. J., Cohen, G. H.
(1999). The Major Neutralizing Antigenic Site on Herpes Simplex Virus Glycoprotein D Overlaps a Receptor-Binding Domain. J. Virol.
73: 9879-9890
[Abstract]
[Full Text]
-
Miyatake, S.-I., Yukawa, H., Toda, H., Matsuoka, N., Takahashi, R., Hashimoto, N., Kontos, C. D.
(1999). Inhibition of Rat Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Recombinant Replication-Competent Herpes Simplex Virus • Editorial Comment. Stroke
30
: 2431-2439
[Abstract]
[Full Text]
-
Thomas, S. K., Lilley, C. E., Latchman, D. S., Coffin, R. S.
(1999). Equine Herpesvirus 1 Gene 12 Can Substitute for vmw65 in the Growth of Herpes Simplex Virus (HSV) Type 1, Allowing the Generation of Optimized Cell Lines for the Propagation of HSV Vectors with Multiple Immediate-Early Gene Defects. J. Virol.
73: 7399-7409
[Abstract]
[Full Text]
-
Chung, R. Y., Saeki, Y., Chiocca, E. A.
(1999). B-myb Promoter Retargeting of Herpes Simplex Virus gamma 34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells. J. Virol.
73: 7556-7564
[Abstract]
[Full Text]
-
Hunter, W. D., Martuza, R. L., Feigenbaum, F., Todo, T., Mineta, T., Yazaki, T., Toda, M., Newsome, J. T., Platenberg, R. C., Manz, H. J., Rabkin, S. D.
(1999). Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates. J. Virol.
73: 6319-6326
[Abstract]
[Full Text]
-
Aghi, M., Chou, T. C., Suling, K., Breakefield, X. O., Chiocca, E. A.
(1999). Multimodal Cancer Treatment Mediated by a Replicating Oncolytic Virus That Delivers the Oxazaphosphorine/Rat Cytochrome P450 2B1 and Ganciclovir/Herpes Simplex Virus Thymidine Kinase Gene Therapies. Cancer Res.
59: 3861-3865
[Abstract]
[Full Text]
-
Kooby, D. A., Carew, J. F., Halterman, M. W., Mack, J. E., Bertino, J. R., Blumgart, L. H., Federoff, H. J., Fong, Y.
(1999). Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J.
13: 1325-1334
[Abstract]
[Full Text]
-
Sarrias, M. R., Whitbeck, J. C., Rooney, I., Spruce, L., Kay, B. K., Montgomery, R. I., Spear, P. G., Ware, C. F., Eisenberg, R. J., Cohen, G. H., Lambris, J. D.
(1999). Inhibition of Herpes Simplex Virus gD and Lymphotoxin-alpha Binding to HveA by Peptide Antagonists. J. Virol.
73: 5681-5687
[Abstract]
[Full Text]
-
Holt, J. R., Johns, D. C., Wang, S., Chen, Z.-Y., Dunn, R. J., Marban, E., Corey, D. P.
(1999). Functional Expression of Exogenous Proteins in Mammalian Sensory Hair Cells Infected With Adenoviral Vectors. J. Neurophysiol.
81: 1881-1888
[Abstract]
[Full Text]
-
Zachos, G., Clements, B., Conner, J.
(1999). Herpes Simplex Virus Type 1 Infection Stimulates p38/c-Jun N-terminal Mitogen-activated Protein Kinase Pathways and Activates Transcription Factor AP-1. J. Biol. Chem.
274: 5097-5103
[Abstract]
[Full Text]
-
Leib, D. A., Harrison, T. E., Laslo, K. M., Machalek, M. A., Moorman, N. J., Virgin, H. W.
(1999). Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo. J. Exp. Med.
189: 663-672
[Abstract]
[Full Text]
-
Smith, C. C., Peng, T., Kulka, M., Aurelian, L.
(1998). The PK Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Is Required for Immediate-Early Gene Expression and Virus Growth. J. Virol.
72: 9131-9141
[Abstract]
[Full Text]
-
Lamberti, C., Weller, S. K.
(1998). The Herpes Simplex Virus Type 1 Cleavage/Packaging Protein, UL32, Is Involved in Efficient Localization of Capsids to Replication Compartments. J. Virol.
72: 2463-2473
[Abstract]
[Full Text]
-
Nelson, J. W., Zhu, J., Smith, C. C., Kulka, M., Aurelian, L.
(1996). ATP and SH3 Binding Sites in the Protein Kinase of the Large Subunit of Herpes Simplex Virus Type 2of Ribonucleotide Reductase (ICP10). J. Biol. Chem.
271: 17021-17027
[Abstract]
[Full Text]
-
Todo, T., Martuza, R. L., Rabkin, S. D., Johnson, P. A.
(2001). Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc. Natl. Acad. Sci. USA
98: 6396-6401
[Abstract]
[Full Text]
Copyright © 1988 by the American Society for Microbiology. All rights reserved.